Glecaprevir–pibrentasvir to treat chronic hepatitis C virus infection in Asia: two multicentre, phase 3 studies—a randomised, double-blind study (VOYAGE-1) and an open-label, single-arm study (VOYAGE-2)
| Autor: | Wei, Lai, Wang, Guiqiang, Alami, Negar N, Xie, Wen, Heo, Jeong, Xie, Qing, Zhang, Mingxiang, Kim, Yoon Jun, Lim, Seng Gee, Fredrick, Linda M, Lu, Wenjing, Liu, Wei, Kalluri, Hari V, Krishnan, Preethi, Tripathi, Rakesh, Mobashery, Niloufar, Burroughs, Margaret, Asatryan, Armen, Jia, Jidong, Hou, Jinlin * |
|---|---|
| Zdroj: | In The Lancet Gastroenterology & Hepatology September 2020 5(9):839-849 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|